Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
Primary Objective:
Secondary Objectives:
Pharmacodynamic objectives:
Pharmacokinetic objective:
Safety objective:
Full description
Duration of treatment: two study days separated by a 7-day wash-out period
Duration of observation:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Primary purpose
Allocation
Interventional model
Masking
37 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal